Related Experiment Video
Updated: Jul 24, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia
Aidan T Hanrath1,2, Catherine F Hatton1,2, Florian Gothe1
1Immunology and Inflammation Theme, Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom.
Abstract:
Macrophages are key target cells of Zika virus (ZIKV) infection, implicated as a viral reservoir seeding sanctuary sites such as the central nervous system and testes. This rests on the apparent ability of macrophages to sustain ZIKV replication without experiencing cytopathic effects. ZIKV infection of macrophages triggers an innate immune response involving type I interferons (IFN-I), key antiviral cytokines that play a complex role in ZIKV pathogenesis in animal models. To investigate the functional role of the IFN-I response we generated human induced pluripotent stem cell (iPSC)-derived macrophages from a patient with complete deficiency of IFNAR2, the high affinity IFN-I receptor subunit. Accompanying the profound defect of IFN-I signalling in IFNAR2 deficient iPS-macrophages we observed significantly enhanced ZIKV replication and cell death, revealing the inherent cytopathicity of ZIKV towards macrophages. These observations were recapitulated by genetic and pharmacological ablation of IFN-I signalling in control iPS-macrophages and extended to a model of iPS-microglia. Thus, the capacity of macrophages to support noncytolytic ZIKV replication depends on an equilibrium set by IFN-I, suggesting that innate antiviral responses might counterintuitively promote ZIKV persistence via the maintenance of tissue viral reservoirs relevant to pathogenesis.
Insights
Type I interferons (IFN-I) normally control Zika virus (ZIKV) replication in macrophages. Disrupting IFN-I signaling paradoxically enhances ZIKV replication and cell death, revealing its pathogenic role.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Macrophages are primary targets for Zika virus (ZIKV) infection, potentially serving as viral reservoirs.
- ZIKV infection in macrophages triggers type I interferons (IFN-I), crucial antiviral cytokines with complex roles in pathogenesis.
- The ability of macrophages to support ZIKV replication without cell death is not fully understood.
Purpose of the Study:
- To investigate the functional role of the IFN-I response in ZIKV infection of human macrophages.
- To determine if IFN-I signaling is essential for controlling ZIKV replication and cytopathicity in macrophages.
Main Methods:
- Generated human induced pluripotent stem cell (iPSC)-derived macrophages from a patient with a complete deficiency of IFNAR2, the IFN-I receptor subunit.
- Assessed ZIKV replication and cell death in IFNAR2-deficient iPS-macrophages.
- Confirmed findings by genetically and pharmacologically inhibiting IFN-I signaling in control iPS-macrophages and iPS-microglia.
Main Results:
- IFNAR2-deficient iPS-macrophages exhibited profoundly defective IFN-I signaling.
- These cells showed significantly enhanced ZIKV replication and increased cell death compared to controls.
- Inhibition of IFN-I signaling in control cells recapitulated these findings, demonstrating ZIKV's inherent cytopathicity towards macrophages.
- These effects were also observed in iPS-microglia.
Conclusions:
- The capacity of macrophages to sustain ZIKV replication without causing cell death is dependent on the balance of IFN-I signaling.
- IFN-I signaling is critical for controlling ZIKV replication and preventing cytopathic effects in macrophages.
- Innate antiviral responses, specifically IFN-I, may paradoxically contribute to ZIKV persistence and pathogenesis by maintaining viral reservoirs.
Related Concept Videos
Arboviral Encephalitis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

